Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
Antiviral Therapy
|
September 2, 2016
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)
Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, et al.
Plos One
|
January 11, 2017
Point-of-Care Versus Central Laboratory Measurements of Hemoglobin, Hematocrit, Glucose, Bicarbonate and Electrolytes: A Prospective Observational Study in Critically Ill Patients
Jérôme Allardet-Servent, Melissa Lebsir, Christian Dubroca, et al.
HIV Clinical Trials
|
April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study
Isabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
European Journal of Immunology
|
November 23, 2011
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Béziat, Olav Dalgard, Tarik Asselah, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2013
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors
Lavanya Bondada, Ramu Rondla, Ugo Pradere, et al.
Journal of Hepatology
|
February 25, 2016
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir
Harel Dahari, Laetitia Canini, Frederik Graw, et al.
Journal of Hepatology
|
May 25, 2010
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection
Paul Calès, Philippe Halfon, Dominique Batisse, et al.
Journal of Hepatology
|
January 29, 2008
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa
Jean-Pierre Bronowicki, Idrissia Abdelmouttaleb, Laurent Peyrin-Biroulet, et al.
Plos One
|
April 28, 2023
Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
Philippe Halfon, Sylvie Jordana, Stéphane Blachier, et al.
BMC Gastroenterology
|
October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver disease
Thierry Poynard, Rachel Morra, Philippe Halfon, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
Antiviral Therapy
|
September 2, 2016
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)
Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, et al.
Plos One
|
January 11, 2017
Point-of-Care Versus Central Laboratory Measurements of Hemoglobin, Hematocrit, Glucose, Bicarbonate and Electrolytes: A Prospective Observational Study in Critically Ill Patients
Jérôme Allardet-Servent, Melissa Lebsir, Christian Dubroca, et al.
HIV Clinical Trials
|
April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study
Isabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
European Journal of Immunology
|
November 23, 2011
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Béziat, Olav Dalgard, Tarik Asselah, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 19, 2013
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors
Lavanya Bondada, Ramu Rondla, Ugo Pradere, et al.
Journal of Hepatology
|
February 25, 2016
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir
Harel Dahari, Laetitia Canini, Frederik Graw, et al.
Journal of Hepatology
|
May 25, 2010
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection
Paul Calès, Philippe Halfon, Dominique Batisse, et al.
Journal of Hepatology
|
January 29, 2008
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa
Jean-Pierre Bronowicki, Idrissia Abdelmouttaleb, Laurent Peyrin-Biroulet, et al.
Plos One
|
April 28, 2023
Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
Philippe Halfon, Sylvie Jordana, Stéphane Blachier, et al.
BMC Gastroenterology
|
October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver disease
Thierry Poynard, Rachel Morra, Philippe Halfon, et al.
Page
of 16